Latest Still River Systems Inc. Stories
LITTLETON, Mass., June 22, 2011 /PRNewswire/ -- Still River Systems, Inc.
LITTLETON, Mass., Oct. 26 /PRNewswire/ -- Still River Systems' groundbreaking proton therapy system is entering the final phase of installation at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St.
WESTMINSTER, Mass., May 24 /PRNewswire-FirstCall/ -- TechPrecision Corporation (OTC Bulletin Board: TPCS) ("TechPrecision", or "the Company"), a leading manufacturer of large-scale, high-precision machined metal fabrications with customers in the alternative energy, medical, nuclear, defense, aerospace and other commercial industries, today reported that its customer, Still River Systems, Inc., has successfully extracted a clinical beam from the first production unit of the world's smallest...
LITTLETON, Mass., May 14 /PRNewswire/ -- Still River Systems, Inc. announces successful clinical beam extraction from the first production unit of the world's smallest high-energy proton therapy accelerator.
LITTLETON, Mass., Sept. 8 /PRNewswire/ -- Still River Systems, Inc., a privately held medical device manufacturer developing a revolutionary, affordable proton therapy delivery system for the treatment of cancer, today announced that the company has appointed Joseph K.
LITTLETON, Mass., March 17 /PRNewswire/ -- Still River Systems, Inc., a provider of proton therapy solutions, announced today the closing of a private financing round of $33 million co-led by Venrock Associates and existing investor Caxton Health and Life Sciences, with participation by CHL Medical Partners.
JACKSONVILLE, Fla., Sept. 17 /PRNewswire/ -- Scot Ackerman, M.D., Medical Director, First Coast Oncology, Jacksonville, FL is pleased to announce the recent agreement for the placement of the Monarch250(TM) Proton Therapy System from Still River Systems, Inc, in Jacksonville, Florida.
- The parings of haberdine; also, any kind of fragments.